Aug 2026· International Journal of Nanomedicine· Vol 21, pp. 1-43· 0 citations· 296 references
Medicine
TL;DR
The TME of pancreatic cancer is depicted and the designs and performances of TME-transforming NPs in the diagnosis and treatment of pancreatic cancer, as well as the obstacles to be overcome before their clinical translation are reviewed.
Abstract
Abstract Early diagnosis and effective treatment of pancreatic cancer remain major clinical challenges, one of the most aggressive and lethal tumors. The tumor microenvironment (TME) in pancreatic cancer exhibits unique features, including high interstitial fluid pressure (IFP), abnormal blood vessels, hypoxia, acidosis, and excess reactive oxygen species (ROS), all favoring tumor progression and immunosuppression, meanwhile offsetting diagnostic efficiency and treatment efficacy. Thus, the TME of pancreatic cancer is considered as a target of profound theranostic significance. Nanoparticles (NPs) have shown a high profile in bio-imaging and targeted drug delivery. Here, we depicted the TME of pancreatic cancer and reviewed the designs and performances of TME-transforming NPs in the diagnosis and treatment of pancreatic cancer, as well as the obstacles to be overcome before their clinical translation. This review is expected to provide sparks for the early diagnosis and personalized treatment for pancreatic cancer.
Pancreatic cancer is a highly aggressive and lethal malignancy with an exceptionally poor prognosis. Its clinical management is severely hampered by insidious early symptoms, strong invasiveness, intrinsic chemoresistance, and limited efficacy of conventional therapies. Carbon dots (CDs) have shown great promise in pre...
Hao Zhou, Yi-Fan Zhang, Yang Xi· Ageing and Cancer Research &...· 0 citations
The current challenges in PC treatment, the role of PLGA NPs in targeted drug delivery, and future perspectives for clinical translation are discussed, suggesting Integrating PLGA NPs could revolutionize PC therapy, offering hope for improved survival and quality of life.
Nusaiba Al-nemrawi, Ghena Majdi AbuAlna'aj, Razan Ahmad Al Hazaimeh et al.· AAPS PharmSciTech· 0 citations
Abstract Lung cancer remains one of the most prevalent and lethal malignancies worldwide and is characterized by a complex tumor microenvironment (TME), including severe hypoxia, acidosis, elevated glutathione levels, and pronounced immunosuppression. These pathological conditions compromise the efficacy of conventiona...
Keyi Gou, Zhong-Song Zhang, Si-Xian Yi et al.· International Journal of Nan...· 0 citations
This review provides a concise framework for the rational design of programmable, multi-responsive polymeric nanomedicines for TNBC therapy and summarizes recent advances in pH-, redox-, ROS-, hypoxia-, photo- and temperature-responsive polymers.
Adnan Murad Bhayo, Ying Li, Alaa R. Aboushanab et al.· Pharmaceutics· 0 citations
This review systematically summarizes targeted nanomedicines constructed from mainstream carriers, including polymeric, metallic, and biomimetic nanoparticles, and discusses the future prospects of artificial intelligence-assisted optimization strategies for nanomedicine development.
Rui-Chao Li, Ze-Yuan Sun, Si-Nian Li et al.· International Journal of Pha...· 0 citations
The development and drug resistance of breast cancer are closely associated with the heterogeneity of the tumor microenvironment (TME). Immunosuppressive cells, activated matrix components, abnormal vascular networks, and metabolic reprogramming within the TME collectively create a niche that promotes tumor survival. D...
Yan-Cai Liu, Yan-Ran Yang, Jiang-Long Wang et al.· Natural Products and Biopros...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
